Mapi Workshop: The Adaptive Pathways Scientific Concept in Europe
September 4 @ 12:00 - 17:00 UTC+0
Join Mapi for a half-day Workshop in Stockholm presenting the different elements of the adaptive pathway concept as well as discussing its implications and expected impact in the adoption of new innovative treatments in Europe.
111 64 Stockholm
Michael Drummond -Professor of Health, University of York
Matthew Bending - Director, Real World Strategy & Analytics, Mapi Group
Will Maier - Chief Scientific Officer, Director Patient-Centered Sciences, Mapi Group
Mia Malmenäs - Director, Real World Strategy & Analytics, Mapi Group
Gianluca Baio - Lecturer in Statistics and Health Economics, University College London
12:00-13:00 - Lunch
13:00–14:00 - The AP Concept
Michael Drummond, University of York;
Mapi: Presentation and discussion of trends that operated in the background and brought this shift, the overall policy in context, comparison with 21st Century Cures and global trends, additional changes we can expect.
EMA/EC: Presentation of the concept, current state of affairs and expected impact.
14:00–14:50 - First Element: HTA and Patient Involvement
Dr. Matthew Bending, Mapi Group; Will Maier, Mapi Group
HTA agencies involvement and position on the extension of the use of AP and the introduction of multi-stakeholder scientific advice as well as the adaptive pricing/reimbursement in the AP concept. Address to focus on the key learnings from our extensive work with scientific advice: which are the main difficulties faced by our clients (both from an internal alignment and external communication point of view)? Keys to success. The balance thus far.
Presentation to cover both dimensions, the early involvement of patient representatives as an interlocutor in the assessment and the enhanced use of PROs
14:50–15:15 - Coffee Break
15:15–16:00 - Second Element: RWE
Mia Malmenäs, Mapi Group
Primary data collection in the new context. Mapi’s e-CRF technology, Swedish and European registries, challenges and opportunities
16:00–17:00 - Third Element: The Iterative Model
Gianluca Baio; Pharma representative from EFPIA or LIV
Subgroup analysis in modelling. Surrogate endpoints: Validation and acceptability
The trend towards personalized medicine. Change in the business model: from big-to-small to small-to-big. Contributions and expectations
17:00 - Informal Cocktail Reception
Register to attend: